Related Experiment Video
Updated: Feb 3, 2026

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
Published on: October 17, 2025
DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs
Manqing Li1, Elaine Kao2, Dane Malone2
1Section of Molecular Biology, Division of Biological Sciences, University of California, San Diego, La Jolla, CA, USA. m5li@ucsd.edu.
Abstract:
Transcriptome analysis reveals a strong positive correlation between human Schlafen family member 11 (SLFN11) expression and the sensitivity of tumor cells to DNA-damaging agents (DDAs). Here, we show that SLFN11 preferentially inhibits translation of the serine/threonine kinases ATR and ATM upon DDA treatment based on distinct codon usage without disrupting early DNA damage response signaling. Type II transfer RNAs (tRNAs), which include all serine and leucine tRNAs, are cleaved in a SLFN11-dependent manner in response to DDAs. Messenger RNAs encoded by genes with high TTA (Leu) codon usage, such as ATR, display utmost susceptibility to translational suppression by SLFN11. Specific attenuation of tRNA-Leu-TAA sufficed to ablate ATR protein expression and restore the DDA sensitivity of SLFN11-deficient cells. Our study uncovered a novel mechanism of codon-specific translational inhibition via SLFN11-dependent tRNA cleavage in the DNA damage response and supports the notion that SLFN11-deficient tumor cells can be resensitized to DDAs by targeting ATR or tRNA-Leu-TAA.
Insights
Schlafen family member 11 (SLFN11) inhibits tumor cell DNA-damaging agent sensitivity by suppressing ATR and ATM translation via tRNA cleavage. Restoring ATR or tRNA-Leu-TAA can re-sensitize SLFN11-deficient cells to DNA-damaging agents.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Schlafen family member 11 (SLFN11) expression correlates with tumor cell sensitivity to DNA-damaging agents (DDAs).
- The precise mechanism linking SLFN11 to DDA sensitivity remains incompletely understood.
- Understanding SLFN11's role is crucial for developing effective cancer therapies.
Purpose of the Study:
- To elucidate the mechanism by which SLFN11 influences tumor cell response to DDAs.
- To investigate the role of codon usage and tRNA cleavage in SLFN11-mediated translational inhibition.
- To identify potential therapeutic strategies for resensitizing SLFN11-deficient tumors.
Main Methods:
- Transcriptome analysis to identify correlations between SLFN11 and DDA sensitivity.
- Investigating the impact of SLFN11 on the translation of specific kinases (ATR, ATM) upon DDA treatment.
- Analyzing SLFN11-dependent cleavage of Type II tRNAs (serine and leucine tRNAs) in response to DDAs.
- Assessing the effect of tRNA-Leu-TAA attenuation on ATR expression and DDA sensitivity.
Main Results:
- SLFN11 preferentially inhibits ATR and ATM translation through codon usage bias upon DDA treatment.
- SLFN11 induces cleavage of Type II tRNAs, including tRNA-Leu-TAA, in response to DDAs.
- Messenger RNAs with high TTA (Leu) codon usage, like ATR, are highly susceptible to SLFN11-mediated translational suppression.
- Reducing tRNA-Leu-TAA levels effectively blocks ATR protein expression and restores DDA sensitivity in SLFN11-deficient cells.
Conclusions:
- SLFN11 employs a novel mechanism of codon-specific translational inhibition via tRNA cleavage during the DNA damage response.
- SLFN11-deficient tumors can potentially be resensitized to DDAs by targeting ATR or tRNA-Leu-TAA.
- This study provides a mechanistic basis for SLFN11's role in DDA sensitivity and suggests new therapeutic avenues.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Cleavage and Blastulation
Overview of DNA Repair
Chemically...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

